T cells autoreactive to the antigen-presenting molecule CD1a are common in human blood and skin, but the search for natural autoantigens has been confounded by background T cell responses to CD1 proteins and self lipids. After capturing CD1a-lipid complexes, we gently eluted ligands while preserving non-ligand-bound CD1a for testing lipids from tissues. CD1a released hundreds of ligands of two types. Inhibitory ligands were ubiquitous membrane lipids with polar head groups, whereas stimulatory compounds were apolar oils. We identified squalene and wax esters, which naturally accumulate in epidermis and sebum, as autoantigens presented by CD1a. The activation of T cells by skin oils suggested that headless mini-antigens nest within CD1a and displace non-antigenic resident lipids with large head groups. Oily autoantigens naturally coat the surface of the skin; thus, this points to a previously unknown mechanism of barrier immunity.
The autoreactivity of T cells to CD1 antigen-presenting molecules was first described for an αβ T cell clone that recognizes CD1a 1 , which led to a search for self antigens that might bind to CD1 proteins. Although most research has focused on CD1d and natural killer T cells, studies measuring the autoreactivity of T cells to cells that express each type of human CD1 antigen-presenting molecule have identified the highest rates of recognition for CD1a or CD1c 2, 3 . CD1a-or CD1c-autoreactive cells infiltrate the thyroid glands in autoimmune disease 4 . Also, human CD1a-autoreactive T cells in the blood express CLA (cutaneous lymphocyte antigen) and the chemokine receptors CCR4, CCR6 and CCR10, which mediate the migration of these cells to skin 2 . The colocalization of CD1a-expressing Langerhans cells (LCs) and CD1a-autoreactive T cells suggests basic roles for CD1a in skin immunity 5 .
Mammalian lipids that stimulate autoreactive T cells have been identified [6] [7] [8] [9] [10] . Many such lipids were selected for study because they mimic α-galactosylceramide, a potent antigen recognized by natural killer T cells 7, 8, 10 , whereas others were preselected and then used to expand populations of T cells through repeated in vitro immunization 6, 11 . An approach that uses unimmunized T cells to analyze the many types of endogenous lipids expressed in the tissues in which T cells reside would be desirable because such a discovery process is unbiased and focuses on natural antigens. However, endogenous antigens in antigen-presenting cells (APCs) cause background activation of T cells that masks the response of T cells to added lipids in reconstitution assays. Here we used several techniques to overcome such background signals and identified oily autoantigens that lacked carbohydrate or charged head groups. The discovery of antigens lacking polar head groups was unexpected, because known antigens presented by major histocompatibility complex (MHC) molecules 12, 13 and CD1 molecules 14 use hydrogen bonding and ionic interactions to bind T cell antigen receptors (TCRs). Lacking any precedent for the recognition of oils by TCRs, we used structure-function assays and analysis of hundreds of ligands released from CD1a proteins to identify general patterns of antigens that stimulated autoreactivity to CD1a. Whereas lipids with hydrophilic head groups were inhibitory, several lipids that lack head groups stimulated T cells. We propose that small, headless molecules nest within the CD1 groove and are recognized because they do not interfere with contact of the TCR with CD1a.
RESULTS

Autoreactivity of polyclonal T cells to CD1a
Methods have been developed to measure the autoreactivity of T cells to CD1a, CD1b, CD1c and CD1d through the use of K562 human myelogenous leukemia cells transfected to express CD1 molecules 2 . These MHC lo cells function as universal APCs that bypass alloreactivity and detect polyclonal CD1-autoreactive cells from any donor ex vivo. In agreement with a published study using interferon-γ (IFN-γ) as a 'readout' 2 , we detected high rates of autoreactivity to CD1a in an analysis of short-term T cell lines, with release of 1 7 8 VOLUME 15 NUMBER 2 FEBRUARY 2014 nature immunology A r t i c l e s interleukin 2 (IL-2) as a 'readout' . CD1a + APCs generated detectable autoreactivity in T cell cultures from eight of ten donors (Fig. 1a) . Among the various CD1 isoforms, CD1a generated the highest responses in seven of ten donors (Fig. 1a) . Those results, along with evidence that CD1a-autoreactive cells represent between 1% and 10% of all T cells 3 , prompted us to focus on the discovery of autoantigens in the CD1a system, as the most prominent source of CD1-autoreactive T cells in human blood. We derived five human T cell lines (named BC2, DermT, BC5, Bgp and BC14) whose activation was inhibited by the OKT6 blocking antibody to CD1a (anti-CD1a) (Fig. 1b) . These results confirmed that the response was dependent on CD1a and not on other cell-surface determinants.
Isolation of antigenic CD1a complexes from cells
When autoantigens are present in the APCs, CD1-autoreactive T cells show baseline reactivity, which masks responses to any added antigen used in reconstitution assays. Background signaling has been a major impediment to the discovery of endogenous autoantigens, but this problem might be overcome by the dissociation of CD1 proteins from the cells that produce them and the stripping of endogenously loaded ligands from proteins. Also, lipids that elute from CD1a proteins might reflect the types of lipids that are normally loaded onto CD1a proteins in cells, which would allow the identification of both nonstimulatory ligands and stimulatory autoantigens.
Taking advantage of constructs previously designed for other CD1 proteins, we produced biotinylated CD1a proteins with truncation of the transmembrane domain and 'zippered' to β 2 -microglobulin with high yield in HEK293 human embryonic kidney cells 15, 16 (Fig. 2a) . Those proteins had the expected apparent mass and were precipitated by streptavidin beads (Fig. 2a) . When bound to a plate, cell-derived CD1a activated the CD1a-autoreactive T cell line BC2 (Fig. 2b) . Thus, the recombinant CD1a proteins retained the structure needed for activating T cells; this created an APC-free system for identifying antigens.
Autoreactivity to CD1a might occur because of contact of the TCR with CD1 itself in the absence of ligand or with CD1 proteins bound to ubiquitous self molecules 17 . Dideoxymycobactin (DDM) is CD1a ligand known to bind in the A′ and F′ pockets of the CD1a groove 18 and to activate the human T cell line CD8-2 (ref. 19) . DDM suppressed the activation of BC2 cells in a dose-dependent way (Fig. 2c) . Because we washed the culture wells after adding lipid but before adding T cells, the inhibition was probably not due to nonspecific effects of lipid on T cells. The interpretation of a lack of toxicity was further supported when we found that DDM activated CD8-2 cells over the same dose range at which we noted inhibition of BC2 cells (Fig. 2c) . Thus, activation of BC2 cells probably involved the distal surface of CD1a near the groove portal, where DDM binds. However, whether DDM displaced an antigenic self compound or inserted into the groove in a way that blocked contact of the TCR with the previously non-ligand-bound CD1a remained unresolved.
Unloading of ligands occurs over a pH range of 6.5-4, which represents conditions that do not induce irreversible unfolding of CD1a proteins 20 . Brief pretreatment of plate-bound CD1a proteins with an acidic pH, followed by washing at neutral pH, diminished the stimulation of BC2 cells by CD1a (Supplementary Fig. 1 ), which suggested that loss of ligand abrogated the activation of T cells. This indicated that direct recognition of non-ligand-bound CD1a proteins was probably not the mechanism of T cell activation. By producing CD1a and MHC class I proteins in high yield, eluting ligands under mildly acidic conditions and applying concentrated eluents to prestripped CD1a proteins, we demonstrated the transfer of stimulatory substances from CD1a to CD1a but not from MHC class I to CD1a (Fig. 2d) . Thus, endogenous autoantigens exist and are loaded onto CD1a proteins by the cells that produce them.
Binding of the TCR by cellular CD1a complexes
To understand the basis of the autoreactivity of the TCR expressed by BC2 cells (the 'BC2 TCR') to CD1a, we expressed the ectodomains of the BC2 TCR α-and β-chains and measured by surface plasmon resonance the affinity of the BC2 TCR toward to the truncated CD1 proteins derived from HEK293 cells. The autoreactive BC2 TCR bound to cell-derived CD1a proteins ( Fig. 2e) with an affinity value (dissociation constant, 92.7 ± 5.3 µM) similar to that noted for autoreactive TCR-peptide-MHC interactions 21 . Thus, the BC2 TCR bound to cellular CD1a complexes.
Release of chemically diverse cellular ligands from CD1a
Next we attempted to identify both antigenic and non-antigenic ligands that eluted from CD1a in chloroform and methanol. Published studies of CD1d 22, 23 , CD1c 24 and CD1b 25 have identified large numbers of lipid ligands that bind to CD1 proteins. However, the identity of ligands that bind to CD1a has remained unknown. Transmembrane truncation can influence some lipids bound to CD1d proteins 23 and necessarily removes cytoplasmic sequences with tail motifs that mediate recycling to endosomes. However, human CD1a lacks recycling motifs 26 and thus truncated CD1a lacking the transmembrane region would be expected to mimic nonrecycled full-length CD1a, as supported by a study comparing native CD1a and CD1a proteins with truncation of the tail 27 . Analysis of eluents by the sensitive method of nanoelectrospray-infusion mass spectrometry detected more than 100 distinct molecular ions with mass/ charge values between 700 and 1,500 (Fig. 3a) , which indicated that many self molecules bound to CD1a. Focusing on intense ions in the positive mode, we used collision-induced dissociation mass spectrometry to identify four types of sphingolipid ligands: sphingomyelin, trihexosylceramide, ganglioside GM3 and globoside Gb4. In addition, we detected trace signals for triacylglyceride (TAG) ( Fig. 3a and Supplementary Fig. 2 ). In negative-mode analysis, we identified five classes of phosphatidic acid-containing compounds: phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylserine and phosphatidylcholine ( Fig. 3a and Supplementary Fig. 3 ). In each class we detected a range of molecular variants that differed in chain length and unsaturation. Overall, CD1a proteins normally bind a broad range of molecules that differ in the nature of their hydrophilic head groups, which can contain carbohydrates or charged atoms or, in the case of TAG, lack polar head groups (Fig. 3b) .
To better quantify the molecular heterogeneity of CD1a ligands, we took advantage of a published lipidomics platform 25, 28 , which detected 1,336 molecular events in the compounds eluted from CD1a (Fig. 3c) . In the normal phase, retention time correlates with polarity. Using named molecules in this data set (TAG, diacylglyceride (DAG), phosphatidylethanolamine and sphingomyelin) as 'benchmarks' , we classified those molecular events into three groups on the basis of retention time. CD1a ligands distributed somewhat evenly into groups with low (22%), intermediate (31%) or high (47%) polarity (Fig. 3c) . Thus, truncated CD1a proteins that egress through the secretory pathway normally bind hundreds of distinct ligands that span a broad spectrum of polarity.
TAG is an autoantigen
Overexpression of CD1a protein did not produce adequate lipid yield for the complex separation approaches needed to identify the antigenic substances in the eluents. Therefore, we diverted from the goal of assessing only natural cellular molecules and assembled a panel of synthetic or purified lipid standards that approximated or matched the structures of eluted natural compounds (Fig. 3b) or known antigens, such as sulfatide, phosphatidylinositol and phosphatidylethanolamine. Among the diverse glycolipids, phospholipids, sulfolipids and sphingolipids tested, we observed stimulatory responses only to synthetic TAG with three fatty acyl units each with 16 carbon atoms and one double bond (C 16:1 ) (Fig. 3d) , which defined this molecule as an autoantigen for CD1a. This finding was unexpected because TAG lacks a bulky or polar head group, whereas most or all previously known antigens carry carbohydrate, phosphate or other rigid and polar or charged hydrophilic groups, which interact with TCRs. Many glycolipids or phospholipids, including sphingomyelin and phosphatidylcholine, strongly inhibited the baseline response of T cells to CD1a (Fig. 3d) . Such inhibition probably reflected the binding of lipids to CD1a rather than nonspecific effects on T cells, because we washed away excess lipid before adding T cells. Thus, naturally occurring CD1a ligands, especially polar lipids with charged or large carbohydrate groups, were not merely 'ignored' but instead acted as antagonists that inhibited the autoreactivity of BC2 T cells.
Differences in the autoreactivity of human tissues
In contrast to the ubiquitous expression on MHC class I, CD1a is expressed in the periphery only on tissue-resident dendritic cells and is constitutively expressed at extremely high density on epidermal LCs 29, 30 . Such restricted tissue distribution suggests a plausible means for restricting the activation of autoreactive T cells based on the physical separation of antigens and CD1a-expressing APCs 2, 5 . Reconstitution experiments with plate-bound CD1a and lipid extracts of various tissues and cells allowed us to test the segregation hypothesis by determining if all cells and tissues were equally antigenic. Lipid extracts prepared with chloroform and methanol from peripheral blood mononuclear cells, K562 cells, transformed B cells (C1R cells), human myeloid cells (THP-1 cells) and thyroid tissue did not detectably activate BC2 cells and usually showed dose-dependent inhibition below baseline activation thresholds (Fig. 4a) . However, lipid extracts of human epidermis activated BC2 cells in a dose-dependent manner (Fig. 4a) . Our initial npg A r t i c l e s screens of purified lipids suggested that BC2 cells responded to synthetic TAGs (Fig. 3d) , and the human epidermis shows greater enrichment for TAGs than its abundance in other tissues 31 . Therefore, we hypothesized that the relatively selective response to skin might be mediated by this tissue's natural enrichment for TAGs or related apolar lipids.
Normal-phase silica thin-layer chromatography (TLC) separates lipids on the basis of polarity, so hydrophobic lipids show higher retention factors 32 . As expected, TLC analysis of tissue extracts showed that the profile of lipids from epidermis was markedly skewed toward apolar lipids (Fig. 4b) . Relative to the lipid profiles of other cell types, samples from the epidermis produced more intense spots that matched those of the TAG standards and relatively less intense spots that matched those of the phosphatidylcholine and sphingomyelin, which acted as T cell antagonists when tested as purified molecules (Figs. 3d and 4b) .
We next assessed whether the strong activation of BC2 cells by the epidermal lipids resulted from the relatively high content of the unusually hydrophobic lipids in the epidermis. Therefore, we extracted epidermis with a less polar solvent: pure chloroform. Compared with extracts made with a mixture of chloroform and methanol, the chloroform-extracted lipid profile skewed toward more hydrophobic lipids, including TAG, cholesterol esters and wax esters, as shown by TLC (Fig. 4b) . Indeed, extracts of epidermal lipids made with pure chloroform showed enhanced activation of BC2 cells, a result we obtained for all three human donors tested (Fig. 4c) . Whereas chloroform-andmethanol extracts of K562 cells, THP-1 cells and thyroid tissues were inhibitory, chloroform extracts of those same cells and tissues had net T cell-activating effects (Fig. 4d) . Thus, different human tissues had different antigenic potency that was directly correlated with their ratio of apolar lipids to polar lipids. Notably, the epidermis had the highest degree of antigenicity (Fig. 4a,d) , an outcome that matches the corresponding high CD1a expression and CD1a-autoreactive T cell homing to skin.
Identification of endogenous cellular autoantigens
Building on our identification of synthetic TAG as an autoantigen (Fig. 3d) and the correlation of TAG content with the antigenic potency of tissues (Fig. 4) , we sought to directly purify the natural autoantigen(s) from epidermis. Using a solvent system that separates highly apolar lipids 32 , we sprayed preparative TLC plates with water to visualize the most abundant lipid bands (0, 1, 2, 3 and 4). We scraped the silica between each band (0-1, 1-2, 2-3, 3-4 and 4+) in attempt to recover lipids produced at lower concentrations. We preserved a slice of the plate for charring to reveal the location of natural skin lipids compared with that of authentic standards (Fig. 5a) . As expected, analysis of epidermal lipids showed a T cell response to lipids extracted from band 3, which migrated together Figs. 2 and 3 npg with a TAG standard (Fig. 5a) . Thus, natural TAGs (Fig. 5a ) and synthetic TAGs (Fig. 3d) were CD1a autoantigens.
Patterns of autoantigen recognition in tissues
Prior efforts to identify antigens that activate one T cell clone have typically yielded a single kind of stimulatory molecule that is recognized without cross-reactivity to other antigens 33, 34 . Therefore, our finding that BC2 was activated by several epidermal lipids with different retention factors and chemical structures was unexpected. For example, BC2 was activated by lipids in band 2, which migrated together with a free fatty acid standard (Fig. 5a ) and was shown to contain free fatty acids by mass spectrometry ( Supplementary  Fig. 4a ). Also, fraction 3-4 was highly stimulatory, and comparison with standards demonstrated its migration together with TAG or wax ester standards or both (Fig. 5a) . Mass spectrometry analysis detected triglycerides in fraction 3 and fraction 3-4 as well as cholesterol esters in fraction 4 ( Supplementary Fig. 4b-d) . We compared the responses to purified epidermal extracts with the responses to synthetic or natural standards to clarify the role of wax esters or cholesterol esters in stimulating the response and to evaluate the possibility that the antigenicity resulted from trace contaminants in natural lipid samples. Our analysis of synthetic molecules agreed with the results obtained with natural lipids; both showed that TAGs, wax esters and free fatty acids were autoantigens (Fig. 5b) . Thus, several structurally related apolar antigens are produced in human epidermis. However, the responses of T cells to lipid structures were not extremely promiscuous; T cells did not recognize other equivalently hydrophobic molecules, such as cholesterol or cholesterol esters (Fig. 5b) , or self lipids with hydrophilic head groups (Fig. 3b) . 
A r t i c l e s
Instead, T cells recognized three highly apolar classes of skin lipids: wax esters, TAG and fatty acids.
Squalene is a sebaceous autoantigen Skin repels microbes and retains water by creating surface barriers composed of unusually hydrophobic lipids. Therefore, in further studies we sought to explain the high antigenicity of skin by pinpointing the source of antigenic lipids. Our experiments were guided by published evidence showing that apolar lipids naturally concentrate as extracellular lipids present in the stratum corneum and sebum 31, 35, 36 . Sebum is a natural mixture of apolar oils and waxy substances that are normally sequestered in sebaceous glands and are therefore not directly accessible to epidermal compartments or CD1a + LCs. Sebum is secreted through hair follicles or sweat glands, where it normally coats the outermost skin surface. Using tissue microdissection to capture sebaceous glands (Fig. 6a) , we analyzed the lipid content and antigenicity of sebum. In agreement with published reports 31, 36 , the lipid profile was considerably skewed toward hydrophobic lipids, with enrichment for TAG and wax esters (Fig. 6a) . Also, sebum showed considerable enrichment for the apolar terpene squalene 31 (Fig. 6a) . Human sebum from microdissected glands, as well as pure synthetic squalene, strongly activated BC2 cells (Fig. 6b) . Squalene is an unsubstituted terpene lipid that lacks all polar functional groups, so the identification of this antigen provided evidence of the activation of T cells by a compound with extreme apolarity.
Head groups block T cell activation
Crystal structures of CD1-lipid complexes have shown that recognition of lipid antigen typically occurs by interaction of the TCR with charged or polar elements of amphipathic lipids 14, 18 . In contrast, fatty acids (C 16 ), wax esters (C 36 ), TAGs (C 51 ) and squalene (C 30 ) lack highly polar head groups. Also, the lipids identified here were recognized in a cross-reactive way despite large differences in size. The observed patterns of cross-reactivity might be explained by a simple model in which T cells are activated when CD1a is occupied by small hydrophobic antigens nested within the groove. Recognition would not require direct contact of the TCR with the antigen's headgroup or highly specific positioning of the antigen for interaction with the TCR. Instead, such nested apolar lipids might affect the conformation of CD1a from an internal position or cause unloading of lipids whose bulky head groups block the approach of the TCR to CD1a. Building on our initial results suggesting that certain lipid ligands of CD1a inhibit autoreactivity (Fig. 3d) , we undertook more detailed studies to assess the functions of headless and headed ligands of CD1a (Fig. 7a) . First, to confirm that stimulatory lipids bind in the CD1a groove, we measured the extent to which the recognition of squalene, wax esters and fatty acids was blocked by pretreatment of CD1a with DDM or sphingomyelin, which normally seat within one or two pockets of the CD1a groove 18, 37 . In agreement with studies showing ready exchange of endogenous and exogenous lipids in CD1 proteins at the cell surface 38 , T cell activation was reduced or abolished in a dose-dependent way when we pretreated CD1a proteins with increasing concentrations of DDM or sphingomyelin (Fig. 7b) . Those results suggested exchange of lipopeptides or glycolipids for antigenic apolar lipids, as well as a specific inhibitory function for headed antigens (Fig. 7b) . In further support of that conclusion, many CD1a ligands with phosphate, sulfate, carbohydrate, anionic or zwitterionic head groups, which failed to activate BC2 cells in plate-bound assays (Fig. 3d) , also inhibited the autoreactivity to CD1a proteins under controlled conditions (Fig. 7c) . We observed dose-dependent inhibition in all cases in which we applied headed ligands to CD1a freshly derived from cells or CD1a prestripped with acid (Fig. 7c) . Overall, the skin-derived antigens activated T cells independently of all cofactors normally present in APCs. The antigens probably functioned through binding to the CD1a groove in a process that involved exchange of endogenous antigens with nonstimulatory lipids carrying bulky head groups, including certain types of lipids identified here as being normally loaded into CD1a in cells.
Structure-function studies of head group size Next we studied lipids with small or absent head groups, which we compared with lipids with the same or similar alkyl chains but modified to increase or decrease the size and polarity of the head group. For example, fatty acids are partially charged, but the charge is absent in fatty alcohols or methyl esters. Although free fatty acids showed detectable autoreactivity (Figs. 5b and 7d) , blocking the carboxylate group by either strategy resulted in a substantial increase in antigenic potency, which provided gain of function (Fig. 7d) . The wax ester antigen, which contains a weakly polar internal ester, can be rendered more polar by the addition of a glycerol unit to create diacylglycerol or by the further addition of a phosphate group to create phosphodiacylglycerol. Activation was reduced when we added internal esters and free alcohol groups, and recognition was abrogated by a phosphate head group (Fig. 7e) .
To determine whether the observed pattern of activation by hydrophobic headless lipids was a more general feature of CD1a-autoreactive T cells, we tested our initially generated T cell lines for activation by the identified activating ligands for BC2 cells. Although Bgp cells and BC2 cells expressed different TCRs (Supplementary Table 1) , both recognized hydrophobic antigens and showed a similar overall hierarchy of recognition of individual antigens, although the responses of Bgp cells were weaker (Fig. 7f) . The weaker response of Bgp cells to all antigens may explain why in the initial screening with cell-derived truncated CD1a protein, we did not observe activation of this T cell line, even though autoreactivity to full-length CD1a on cells was apparent (Fig. 1) . In summary, contrary to previously known CD1 antigens, CD1a autoantigens are extremely apolar, oily substances that are recognized on the basis of their lack of polar head groups. npg DISCUSSION Antigens are typically positioned partly within grooves in CD1 or MHC molecules but rise up to the plane of TCR contact, which creates a composite surface that is the TCR epitope [12] [13] [14] . The structural constraints of that type of ternary interaction can be used to correctly predict the observed molecular structures of the known antigens for αβ T cells; peptides and lipids generally match or exceed the molecular volume of the grooves they bind. Most antigens contain polar atoms that mediate highly specific interactions with TCRs 12-14 . In contrast, squalene (C 30 ), wax esters (C 36 ), TAGs (C 51 ) and fatty acids (C 16 ) largely lack substrates for hydrogen bonding, and they are recognized in a cross-reactive way despite substantial differences in their size. Notably, squalene, a relatively potent natural CD1a autoantigen, lacks the chemical basis for hydrogen bonding or charge-charge interactions with the TCR. The divergence of those newly discovered structures from previously identified αβ T cell antigens points toward a model for T cell activation whereby skin oils are recognized on the basis of the antigen that creates non-interference with an interaction between CD1a and the TCR. A study of CD1d-reactive TCRs has shown how autoreactivity can be blocked by the addition of bulky lipid ligands 39, 40 , similar to the inhibitory headed ligands of CD1a identified here. Also, CD1b binds small hydrophobic ligands wholly within the groove such that there is no extension to the outside of CD1b, where TCR interaction normally occurs 25, 41 . Here we found that the natural ligands of CD1a were also small hydrophobic molecules, but unlike scaffold lipids in the CD1b system, these ligands activated T cells. In contrast to nonamer peptides or diacylglycerols that are of predictable size and match the volume constraints of their respective antigen-binding grooves, the stimulatory compounds identified here ranged from C 16 to C 51 . These antigens did not match each other in length, nor did they match the volume of CD1a (1,360 Å 3 ), which is optimal for lipids ~C 42 in composition 37 . These cell-free assays do not allow antigen processing, so the diverse sizes are probably maintained until the activating event. Therefore, it is unlikely that the T cell activation is mediated through a single type of homogenous seating of antigens within the CD1a groove, as is typical of known antigens. TAGs (C 51 ) somewhat exceed the expected volume of the CD1a groove (C 42 ) and thus might be recognized through conformational adaptation of CD1a, or the lipid might protrude through the F′ portal, as occurs for cardiolipin in CD1d 42 . Specifically, human CD1a has a notch in the lateral margin of the F′ pocket, which might allow TAG to escape laterally without crossing into the plane of TCR contact 18 .
Two non-mutually exclusive models are that the apolar antigens stabilize the groove or that they displace inhibitory ligands. There is evidence that internally positioned lipids alter the outer CD1 surfaces 38, 43 . The loss of response by BC2 cells after acid-stripping of CD1a proteins would suggest that the latter mechanism is active. However, the dominant mechanism seems to be that apolar antigens displace CD1a ligands with bulky or charged head groups, which would otherwise interfere with the CD1a-TCR contact. In support of the model proposing lack of interference, cellular CD1a proteins bind many ligands with large head groups, and some of those headed ligands block autoreactivity to CD1a. Activation of CD1a-autoreactive T cells does not result from one potent agonist but instead results from the ratio of apolar antigens to polar antigens bound to a 'cohort' of CD1a proteins, so the mechanism is more like a rheostat than an 'on-off ' switch.
Skin oils represent natural tissue-specific autoantigens. The lipid profile of most tissues is dominated by membrane phospholipids and sphingolipids, whose amphipathic character contrasts with the apolar antigens we identified here. Although TAG, fatty acids and squalene can be found in all cells, their extracellular accumulation is restricted mainly to human sebaceous glands and the cornified layer of the epidermis, which are also the locations where unusual wax esters are produced in large quantity 31 . Thus, lipid autoantigens are spatially distributed within defined extracellular subcompartments of the skin. CD1a expression is likewise largely restricted to LCs, which reside predominantly in the suprabasal spinous layer of the epidermis. The discovery of the antigenic properties of skin oils suggests candidate mechanisms by which alterations in lipid content might influence disease. For example, atopic dermatitis and psoriasis are associated with changes in ceramide or other skin lipid composition 44, 45 , and treatments to alleviate symptoms include ointments containing lipids shown here to affect T cell responses 46 . Also, the responses of T cells to the hydrophobic components of oils provide a candidate mechanism to describe the action of hydrophobic skin contact sensitizers, which activate T cells but do so by unknown mechanisms. Finally, squalene is a major component of two adjuvants, MF59 and AS03, which are used in vaccines against influenza virus in Europe but whose mechanisms are not fully known 47 . Thus, the presentation of oils by CD1a represents a candidate mechanism for vaccine adjuvancy.
METHODS
Methods and any associated references are available in the online version of the paper.
